How much does it cost to launch and commercialize a companion diagnostic test?
•
2 likes•4,424 views
We ask four senior executives to come up with a value on how much it would cost to launch and commercialize a novel diagnostic test. View the infographic to see what they came up with. We defined low end as a follow on diagnostic product where a similar test exists in the market and a high end test which is a new biomarker (needing to establish novel clinical utility), or a new platform likely to be in oncology, a chronic disease like rheumatoid arthritis or a range of infectious markers requiring panel performance. Source http://www.diaceutics.com/mystery-solved-what-cost-develop-and-launch-diagnostic#sthash.ryk5zoEa.dpuf
Report
Share
Report
Share
Download to read offline
Recommended
Drug repurposing
Drug repurposing involves finding new uses for existing drugs to treat different diseases. It provides a more efficient and lower cost alternative to traditional drug development. Computational approaches like network-based, text mining, and semantic methods are used to discover novel drug-disease relationships for drug repurposing. These include identifying modules in biological networks, propagating information across networks, extracting relationships from literature, and constructing semantic networks to predict new associations. Drug repurposing reduces costs and risks compared to de novo drug development.
Animal ethics
The document discusses the history of animal ethics and legislation from antiquity to modern times. Some key events include the first known animal protection law passing in Ireland in 1635, philosopher Jeremy Bentham arguing for better treatment of animals in 1780, and the development of the Three Rs principles in the 20th century to promote more humane animal research. The document also examines the rise of animal experimentation and vivisection from the Renaissance onward and the modern animal rights movement starting in the late 20th century.
Lewins genes xi [pdf][tahir99] vrg
This document provides an overview of the textbook Lewin's GENES XI. It begins with a brief description of the contents of the textbook, which is divided into four parts that cover genes and chromosomes, DNA replication and recombination, transcription and posttranscriptional mechanisms, and gene regulation. It then lists the chapter titles in the textbook and provides short descriptions of the focus of each chapter. The document concludes by listing publication details for the textbook such as publisher information, copyright details, and cataloging data.
High throughput screening
This document discusses high throughput screening and cell-based assays. It begins by defining high throughput screening as a process used in drug discovery to quickly assay a large number of compounds against a biological target to identify hits or leads. It then describes some key aspects of high throughput screening methodology including detection methods like spectroscopy, chromatography, and microscopy. The document outlines the advantages of cell-based assays compared to biochemical assays, noting they provide a more accurate representation using live cells. Finally, it defines the key elements of a cell-based assay as having a cellular component, a target molecule, an instrument, and informatics for data analysis.
Clinical trials its types and designs
clinical trials- definition
types of clinical trials
various designs of clinical trials such as observational design and intervention design.
Array technology
Array technology allows for the simultaneous analysis of multiple genes. It has advantages like miniaturization, use of fluorescent labels instead of radioactive labels, and decreased hazardous materials. There are different types of arrays like DNA, RNA, protein, and antibody arrays. DNA microarrays can be used to measure gene expression changes, detect single nucleotide polymorphisms, and identify DNA binding sites. They work by hybridizing fluorescently labeled target sequences to probe sequences on the array, and detecting signals that depend on the strength of hybridization.
Pharmacogenomics & its ethical issues
Humans are 99% similar to each other; but it is the 1% that is the cause of concern. This relatively small difference actually how a drug will effect our body. Pharmacogenomics is the study of how genes affect a person’s response to drugs. In order to prevent any unwanted reactions it has become necessary to consider one's genome while prescribing medicine. Thus pharmacogenomics is the starting point of personalized medicine.
Screening of Antihyperlipidemic drugs
Includes in vivo and in vitro models for the screening of antihyperlipidemic drugs. Types of lipoproteins, their structures and functions.
Recommended
Drug repurposing
Drug repurposing involves finding new uses for existing drugs to treat different diseases. It provides a more efficient and lower cost alternative to traditional drug development. Computational approaches like network-based, text mining, and semantic methods are used to discover novel drug-disease relationships for drug repurposing. These include identifying modules in biological networks, propagating information across networks, extracting relationships from literature, and constructing semantic networks to predict new associations. Drug repurposing reduces costs and risks compared to de novo drug development.
Animal ethics
The document discusses the history of animal ethics and legislation from antiquity to modern times. Some key events include the first known animal protection law passing in Ireland in 1635, philosopher Jeremy Bentham arguing for better treatment of animals in 1780, and the development of the Three Rs principles in the 20th century to promote more humane animal research. The document also examines the rise of animal experimentation and vivisection from the Renaissance onward and the modern animal rights movement starting in the late 20th century.
Lewins genes xi [pdf][tahir99] vrg
This document provides an overview of the textbook Lewin's GENES XI. It begins with a brief description of the contents of the textbook, which is divided into four parts that cover genes and chromosomes, DNA replication and recombination, transcription and posttranscriptional mechanisms, and gene regulation. It then lists the chapter titles in the textbook and provides short descriptions of the focus of each chapter. The document concludes by listing publication details for the textbook such as publisher information, copyright details, and cataloging data.
High throughput screening
This document discusses high throughput screening and cell-based assays. It begins by defining high throughput screening as a process used in drug discovery to quickly assay a large number of compounds against a biological target to identify hits or leads. It then describes some key aspects of high throughput screening methodology including detection methods like spectroscopy, chromatography, and microscopy. The document outlines the advantages of cell-based assays compared to biochemical assays, noting they provide a more accurate representation using live cells. Finally, it defines the key elements of a cell-based assay as having a cellular component, a target molecule, an instrument, and informatics for data analysis.
Clinical trials its types and designs
clinical trials- definition
types of clinical trials
various designs of clinical trials such as observational design and intervention design.
Array technology
Array technology allows for the simultaneous analysis of multiple genes. It has advantages like miniaturization, use of fluorescent labels instead of radioactive labels, and decreased hazardous materials. There are different types of arrays like DNA, RNA, protein, and antibody arrays. DNA microarrays can be used to measure gene expression changes, detect single nucleotide polymorphisms, and identify DNA binding sites. They work by hybridizing fluorescently labeled target sequences to probe sequences on the array, and detecting signals that depend on the strength of hybridization.
Pharmacogenomics & its ethical issues
Humans are 99% similar to each other; but it is the 1% that is the cause of concern. This relatively small difference actually how a drug will effect our body. Pharmacogenomics is the study of how genes affect a person’s response to drugs. In order to prevent any unwanted reactions it has become necessary to consider one's genome while prescribing medicine. Thus pharmacogenomics is the starting point of personalized medicine.
Screening of Antihyperlipidemic drugs
Includes in vivo and in vitro models for the screening of antihyperlipidemic drugs. Types of lipoproteins, their structures and functions.
Animal ethics committee in INDIA
Presentation focuses on historical development of Animal experimentation related rules and regulations and present status in INDIA.
Guidelines for Preparation of Documents, Clinical Study Report Clinical Trial...
Contents
Guidelines for Preparation of Documentation
Clinical Study Reports
Clinical Trial Monitoring
Safety Monitoring in clinical trials
Introduction
Proper documentation is critical to the success of a clinical study.
Every aspect of the study must be documented in order to obtain useful data and demonstrate compliance with Good Clinical Practice (GCP) guidelines and with all applicable regulations.
Investigator’s Brochure (IB)
List of Abbreviations
Contents & Summary
Introduction provides the chemical name (and generic and trade names, if approved) of the investigational product.
Physical, chemical and pharmaceutical properties and formulation of the medicinal product. Non-clinical studies & Clinical Studies and their results.
The Investigator's Brochure should be reviewed at least annually and revised as necessary in compliance with a standard procedures established by drug development company.
Applications of proteomic sciences
Proteomics is the study of proteins, including their composition, structure, function and interactions. There are two main types: interaction proteomics which identifies protein-protein interactions and complexes; and expression proteomics which quantifies protein levels. Proteomics has applications in new drug discovery by identifying proteins involved in diseases and developing drugs that target those proteins. Genomics studies genomes and their structure, function and evolution. It has applications in molecular medicine, disease susceptibility, forensics and agriculture. Metabolomics studies small molecule metabolites within cells, tissues and organisms and their interactions. It has applications in pharmacology, toxicology and clinical chemistry. Nutrigenomics studies the effects of food on gene expression and identifies genes involved in physiological
Limitations of animal models part 1
Animal studies have several limitations for predicting human outcomes, including interspecies differences in disease susceptibility, pharmacokinetics, and responses to stress. Studies in stressful laboratory environments and using chronic high doses can distort results. Alternatives to animal testing are needed and should incorporate the principles of reduction, replacement, and refinement. These include addressing methodological issues in animal experiments like small sample sizes, lack of randomization and blinding, and conflicts of interest. The external validity of animal models is reduced due to differences between young, healthy research animals and elderly, comorbid human patients.
Animal models
This document defines animal models and discusses their use in research. It defines an animal model as a living organism that resembles a pathological process in humans. Major advances involving animal models are described from the 1600s to present day, including vaccination and understanding of infectious disease. Common animal models used are then outlined, including rodents like rats, mice and guinea pigs as well as non-rodents like rabbits, monkeys, cats and dogs. The document discusses specific uses and characteristics of different animal models and alternatives to animal testing.
Understanding Clinical Trials
This document provides an overview of clinical trials, including their purpose, classifications, terminology, design, phases, ethics, and protections for participants. Some key points:
- Clinical trials test interventions like drugs or procedures and compare them to standard practices or placebos. They progress through phases to test safety and effectiveness.
- There are three main types of research studies: observational studies that compare groups, analytic studies that test therapies, and clinical trials which are considered the "gold standard" experimental study.
- Protections like informed consent and institutional review boards ensure ethical treatment of human subjects and that risks are reasonable compared to potential benefits. Oversight protects participants' rights and welfare.
OECD Guidelines
The Slides present guidelines for Acute oral testing of drugs as well as other OECD guidelines in short.
Discovery of Drug and Introduction to Clinical Trial_Katalyst HLS
Introduction to Discovery of Drug and Introduction to Clinical Trials in Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
Alzheimer models
The document summarizes screening models for Alzheimer's disease. It describes two in vitro methods - inhibition of acetylcholine-esterase activity in rat striatum and inhibition of butyrylcholine-esterase activity in human serum. It also describes two in vivo methods - the step-down test and scopolamine-induced amnesia in mice. The step-down test measures learning and memory in rats using an elevated platform and electric shock. The scopolamine-induced amnesia test measures the ability of drugs to reverse memory deficits caused by the antimuscarinic scopolamine in mice. The document provides details on the procedures and evaluations of these screening methods.
Risk minimisation activities - measuring effectiveness
This presentation describes approaches to evaluating the effectiveness of risk minimisation programmes.
Quality Control of Sequencing Data
This was presented on Mar 31, 2015 at Boyce Thompson Institute, Ithaca, NY at the 3rd BTI Bioinformatics Course http://btiplantbioinfocourse.wordpress.com/
[PDF]book Principles and Practice of Clinical Research
Copy Link to Get Book : https://reader.ebookexprees.com/B0771LNP18/Principles-and-Practice-of-Clinical-Research.pdf
Ethics of Using animals in Research
Today there exists a wide spectrum of views on this subject, ranging from those concerned with animal 'rights' to those who view animals only as a resource to be exploited.
All of thThe five freedoms were originally developed from a UK Government report on livestock husbandry in 1965 (Prof.Roger Brambell) then by Farm Animal Welfare Council (FAWC) In July 1979
Freedom from hunger or thirst by ready access to fresh water and a diet to maintain full health and vigour .
Freedom from discomfort by providing an appropriate environment including shelter and a comfortable resting area .
Freedom from pain, injury or disease by prevention or rapid diagnosis and treatment.
Freedom to express (most) normal behaviour by providing sufficient space, proper facilities and company of the animal's own kind.
Freedom from fear and distress by ensuring conditions and treatment which avoid mental suffering.
Role of AI in Drug Discovery and Development
Role of artificial intelligence in drug discovery and development From Lead selection, clinical trails, pharmacovigilance
Documentation clinical trial
Clinical trials are research studies performed in humans to test new drugs or treatments. They follow a multi-phase process to test safety and efficacy. The document defines clinical trials and describes their purpose to discover or verify clinical and pharmacological effects of investigational products. It also outlines the different types of clinical trials including treatment, prevention, and screening trials. The phases of clinical trials are explained including phases I-III. Key documents for clinical trials are also listed such as the investigator's brochure, clinical study protocol, case report forms, informed consent forms, and clinical study reports.
RT-PCR
Real-time PCR allows for amplification of DNA to be monitored in real-time through the use of fluorescent dyes. It has advantages over traditional PCR such as a wider dynamic range and faster cycling. There are different fluorescent dyes and probe types that can be used for real-time PCR, including SYBR Green and TaqMan probes, which allow for quantification of amplification. Real-time PCR can be used for both absolute and relative quantification of DNA or RNA targets.
Artificial intelligence in drug discovery and development
Artificial intelligence in drug discovery and development. Use of AI in various sectors in pharmacy, Explained a Review paper of AI use in drug design
Introduction to bioethics
This document summarizes the differing early understandings and uses of the term "bioethics" put forth by Van Rensselaer Potter and scholars at Georgetown University. While Potter conceived of bioethics as addressing broad environmental and public health issues, Georgetown focused it more narrowly on medical ethics issues. Though initially at odds, the document argues Hellegers at Georgetown also envisioned a global scope for bioethics. It analyzes how Georgetown's definition became dominant due to various intellectual, practical, and institutional factors while Potter's view remained marginalized, despite his role in coining the term.
Alternatives to animal studies
Alternatives to animal studies in Pharmaceutical research has been explained on the basis of replacement, reduction and refinement. Also newer pre-clinical animal models like use of genetically modified animals were presented.
Drug discovery and development
The document discusses the process for approval of a new drug from development through marketing. It takes 10-15 years on average and costs over $2.6 billion to get a new drug approved. Key steps include:
- Preclinical research to identify biological targets and compounds
- FDA approval to begin clinical trials in three phases involving thousands of subjects to test safety, efficacy, and dosing
- New Drug Application submission including all clinical trial data for FDA review and approval
- Post-marketing studies and generic approval after patents expire
The Past, Present, and Future of Cardiac Biomarkers
This presentation discusses the past, present, and future of cardiac biomarkers for diagnosing acute cardiac events like myocardial infarction. It reviews earlier biomarkers like CK-MB and LDH and the current gold standards of cardiac troponins. Emerging biomarkers discussed include H-FABP, GPBB, ST2, and microRNAs, which may allow for earlier diagnosis. The goals of using multiple biomarkers are to determine the presence, type, and severity of cardiac tissue damage. Overall, biomarkers have progressed from being used retrospectively to becoming a diagnostic standard and influencing treatment decisions.
Reimbursement Strategy for Companion Diagnostics
Summary of reimbursement issues and related business strategy concerns for commercialization of companion diagnostics
More Related Content
What's hot
Animal ethics committee in INDIA
Presentation focuses on historical development of Animal experimentation related rules and regulations and present status in INDIA.
Guidelines for Preparation of Documents, Clinical Study Report Clinical Trial...
Contents
Guidelines for Preparation of Documentation
Clinical Study Reports
Clinical Trial Monitoring
Safety Monitoring in clinical trials
Introduction
Proper documentation is critical to the success of a clinical study.
Every aspect of the study must be documented in order to obtain useful data and demonstrate compliance with Good Clinical Practice (GCP) guidelines and with all applicable regulations.
Investigator’s Brochure (IB)
List of Abbreviations
Contents & Summary
Introduction provides the chemical name (and generic and trade names, if approved) of the investigational product.
Physical, chemical and pharmaceutical properties and formulation of the medicinal product. Non-clinical studies & Clinical Studies and their results.
The Investigator's Brochure should be reviewed at least annually and revised as necessary in compliance with a standard procedures established by drug development company.
Applications of proteomic sciences
Proteomics is the study of proteins, including their composition, structure, function and interactions. There are two main types: interaction proteomics which identifies protein-protein interactions and complexes; and expression proteomics which quantifies protein levels. Proteomics has applications in new drug discovery by identifying proteins involved in diseases and developing drugs that target those proteins. Genomics studies genomes and their structure, function and evolution. It has applications in molecular medicine, disease susceptibility, forensics and agriculture. Metabolomics studies small molecule metabolites within cells, tissues and organisms and their interactions. It has applications in pharmacology, toxicology and clinical chemistry. Nutrigenomics studies the effects of food on gene expression and identifies genes involved in physiological
Limitations of animal models part 1
Animal studies have several limitations for predicting human outcomes, including interspecies differences in disease susceptibility, pharmacokinetics, and responses to stress. Studies in stressful laboratory environments and using chronic high doses can distort results. Alternatives to animal testing are needed and should incorporate the principles of reduction, replacement, and refinement. These include addressing methodological issues in animal experiments like small sample sizes, lack of randomization and blinding, and conflicts of interest. The external validity of animal models is reduced due to differences between young, healthy research animals and elderly, comorbid human patients.
Animal models
This document defines animal models and discusses their use in research. It defines an animal model as a living organism that resembles a pathological process in humans. Major advances involving animal models are described from the 1600s to present day, including vaccination and understanding of infectious disease. Common animal models used are then outlined, including rodents like rats, mice and guinea pigs as well as non-rodents like rabbits, monkeys, cats and dogs. The document discusses specific uses and characteristics of different animal models and alternatives to animal testing.
Understanding Clinical Trials
This document provides an overview of clinical trials, including their purpose, classifications, terminology, design, phases, ethics, and protections for participants. Some key points:
- Clinical trials test interventions like drugs or procedures and compare them to standard practices or placebos. They progress through phases to test safety and effectiveness.
- There are three main types of research studies: observational studies that compare groups, analytic studies that test therapies, and clinical trials which are considered the "gold standard" experimental study.
- Protections like informed consent and institutional review boards ensure ethical treatment of human subjects and that risks are reasonable compared to potential benefits. Oversight protects participants' rights and welfare.
OECD Guidelines
The Slides present guidelines for Acute oral testing of drugs as well as other OECD guidelines in short.
Discovery of Drug and Introduction to Clinical Trial_Katalyst HLS
Introduction to Discovery of Drug and Introduction to Clinical Trials in Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
Alzheimer models
The document summarizes screening models for Alzheimer's disease. It describes two in vitro methods - inhibition of acetylcholine-esterase activity in rat striatum and inhibition of butyrylcholine-esterase activity in human serum. It also describes two in vivo methods - the step-down test and scopolamine-induced amnesia in mice. The step-down test measures learning and memory in rats using an elevated platform and electric shock. The scopolamine-induced amnesia test measures the ability of drugs to reverse memory deficits caused by the antimuscarinic scopolamine in mice. The document provides details on the procedures and evaluations of these screening methods.
Risk minimisation activities - measuring effectiveness
This presentation describes approaches to evaluating the effectiveness of risk minimisation programmes.
Quality Control of Sequencing Data
This was presented on Mar 31, 2015 at Boyce Thompson Institute, Ithaca, NY at the 3rd BTI Bioinformatics Course http://btiplantbioinfocourse.wordpress.com/
[PDF]book Principles and Practice of Clinical Research
Copy Link to Get Book : https://reader.ebookexprees.com/B0771LNP18/Principles-and-Practice-of-Clinical-Research.pdf
Ethics of Using animals in Research
Today there exists a wide spectrum of views on this subject, ranging from those concerned with animal 'rights' to those who view animals only as a resource to be exploited.
All of thThe five freedoms were originally developed from a UK Government report on livestock husbandry in 1965 (Prof.Roger Brambell) then by Farm Animal Welfare Council (FAWC) In July 1979
Freedom from hunger or thirst by ready access to fresh water and a diet to maintain full health and vigour .
Freedom from discomfort by providing an appropriate environment including shelter and a comfortable resting area .
Freedom from pain, injury or disease by prevention or rapid diagnosis and treatment.
Freedom to express (most) normal behaviour by providing sufficient space, proper facilities and company of the animal's own kind.
Freedom from fear and distress by ensuring conditions and treatment which avoid mental suffering.
Role of AI in Drug Discovery and Development
Role of artificial intelligence in drug discovery and development From Lead selection, clinical trails, pharmacovigilance
Documentation clinical trial
Clinical trials are research studies performed in humans to test new drugs or treatments. They follow a multi-phase process to test safety and efficacy. The document defines clinical trials and describes their purpose to discover or verify clinical and pharmacological effects of investigational products. It also outlines the different types of clinical trials including treatment, prevention, and screening trials. The phases of clinical trials are explained including phases I-III. Key documents for clinical trials are also listed such as the investigator's brochure, clinical study protocol, case report forms, informed consent forms, and clinical study reports.
RT-PCR
Real-time PCR allows for amplification of DNA to be monitored in real-time through the use of fluorescent dyes. It has advantages over traditional PCR such as a wider dynamic range and faster cycling. There are different fluorescent dyes and probe types that can be used for real-time PCR, including SYBR Green and TaqMan probes, which allow for quantification of amplification. Real-time PCR can be used for both absolute and relative quantification of DNA or RNA targets.
Artificial intelligence in drug discovery and development
Artificial intelligence in drug discovery and development. Use of AI in various sectors in pharmacy, Explained a Review paper of AI use in drug design
Introduction to bioethics
This document summarizes the differing early understandings and uses of the term "bioethics" put forth by Van Rensselaer Potter and scholars at Georgetown University. While Potter conceived of bioethics as addressing broad environmental and public health issues, Georgetown focused it more narrowly on medical ethics issues. Though initially at odds, the document argues Hellegers at Georgetown also envisioned a global scope for bioethics. It analyzes how Georgetown's definition became dominant due to various intellectual, practical, and institutional factors while Potter's view remained marginalized, despite his role in coining the term.
Alternatives to animal studies
Alternatives to animal studies in Pharmaceutical research has been explained on the basis of replacement, reduction and refinement. Also newer pre-clinical animal models like use of genetically modified animals were presented.
Drug discovery and development
The document discusses the process for approval of a new drug from development through marketing. It takes 10-15 years on average and costs over $2.6 billion to get a new drug approved. Key steps include:
- Preclinical research to identify biological targets and compounds
- FDA approval to begin clinical trials in three phases involving thousands of subjects to test safety, efficacy, and dosing
- New Drug Application submission including all clinical trial data for FDA review and approval
- Post-marketing studies and generic approval after patents expire
What's hot (20)
Guidelines for Preparation of Documents, Clinical Study Report Clinical Trial...
Guidelines for Preparation of Documents, Clinical Study Report Clinical Trial...
Discovery of Drug and Introduction to Clinical Trial_Katalyst HLS
Discovery of Drug and Introduction to Clinical Trial_Katalyst HLS
Risk minimisation activities - measuring effectiveness
Risk minimisation activities - measuring effectiveness
[PDF]book Principles and Practice of Clinical Research
[PDF]book Principles and Practice of Clinical Research
Artificial intelligence in drug discovery and development
Artificial intelligence in drug discovery and development
Viewers also liked
The Past, Present, and Future of Cardiac Biomarkers
This presentation discusses the past, present, and future of cardiac biomarkers for diagnosing acute cardiac events like myocardial infarction. It reviews earlier biomarkers like CK-MB and LDH and the current gold standards of cardiac troponins. Emerging biomarkers discussed include H-FABP, GPBB, ST2, and microRNAs, which may allow for earlier diagnosis. The goals of using multiple biomarkers are to determine the presence, type, and severity of cardiac tissue damage. Overall, biomarkers have progressed from being used retrospectively to becoming a diagnostic standard and influencing treatment decisions.
Reimbursement Strategy for Companion Diagnostics
Summary of reimbursement issues and related business strategy concerns for commercialization of companion diagnostics
Cardiac Biomarkers by sandip
Cardiac biomarkers provide information about heart damage and heart failure. Commonly used cardiac biomarkers include creatine kinase-MB (CK-MB), myoglobin, cardiac troponins, and natriuretic peptides.
CK-MB and myoglobin levels begin to rise earlier than cardiac troponins after a heart attack, but they are less specific to the heart. Cardiac troponins are now the gold standard biomarkers for detecting myocardial injury since they remain elevated for longer and are highly specific to the heart.
Natriuretic peptides indicate heart failure and volume overload of the heart. Together, cardiac biomarkers can provide information about myocardial injury, ischemia, heart failure, and prognosis when clinical assessment is inconclusive
Cardiac Biomarkers
Cardiac biomarkers are indicators used to objectively measure and evaluate normal biological processes, responses to treatment, and pathogenic processes in the heart. They have numerous advantages over traditional diagnostic tests as they are standardized, sensitive, specific, reproducible, and easy to interpret. This document discusses several cardiac biomarkers including C-reactive protein, soluble CD40 ligand, homocysteine, pregnancy-associated plasma protein A, lipoprotein-associated phospholipase A2, ischemia modified albumin, heart-type fatty acid binding protein, cardiac troponins, and creatine kinase. It provides details on what each biomarker indicates, their clinical uses, limitations, normal ranges, and timing of elevation following cardiac events.
Recent advances in the role of Cardiac bio-markers for clinical practice
This document discusses various cardiac biomarkers used in the diagnosis and management of acute coronary syndrome (ACS) and myocardial infarction (MI). It provides information on biomarkers such as creatine kinase (CK), CK-MB isoenzyme, cardiac troponins, myoglobin, and others. It describes the timing of elevation, specificity, and clinical utility of each biomarker as well as situations where they may be falsely elevated or chronically elevated in conditions like heart failure or renal disease. Newer emerging biomarkers are also mentioned.
Cardiac Biomarker past, today and future by Dr. Anurag Yadav
Cardiac biomarkers provide information about cardiac conditions by detecting substances released when the heart muscle is damaged. Over time, newer biomarkers like cardiac troponins (cTnT and cTnI) and myoglobin have improved on older markers like CK-MB for diagnosing myocardial infarction. Biomarkers are classified based on whether they indicate injury, ischemia, stress, inflammation, or prognosis. Their levels rise and fall at different rates, allowing physicians to determine the timing and extent of cardiac events. Beyond diagnostics, certain biomarkers like CRP, homocysteine, and miRNAs may directly influence cardiovascular risk and pathogenesis.
13 Steve Jobs Quotes About Design
The best 13 quotes from the late, great Steve Jobs and how he has inspired my approach to product design.
oSnap:
http://osnapapp.com/
Photo Credit:
http://www.fullhdwallpapers3d.com/
Viewers also liked (7)
The Past, Present, and Future of Cardiac Biomarkers
The Past, Present, and Future of Cardiac Biomarkers
Recent advances in the role of Cardiac bio-markers for clinical practice
Recent advances in the role of Cardiac bio-markers for clinical practice
Cardiac Biomarker past, today and future by Dr. Anurag Yadav
Cardiac Biomarker past, today and future by Dr. Anurag Yadav
Similar to How much does it cost to launch and commercialize a companion diagnostic test?
Drug Development Life Cycle - Costs and Revenue
Presentation explains the Drug Development Process in terms of time/costs from initial research to final manufacturing. It presents strategies for increasing profits/decreasing costs, shows the impact of generics and details how Information Technology fits into this equation. It uses research from DiMasi and Grabowski to identify drug costs and product revenue.
Emba Strategic Dilemma April 2009
This is the Strategic Dilemma project my Executive MBA team presented in April 2009. The company we were working with is in the Pharmaceutical Drug Development Industry. There are slides showing the timeline for drug development and how this company could reduce the time to market for drugs.
CASE STUDY ON CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
This document provides an analysis for a corporate venture capital fund to identify potential investment targets in the point-of-care diagnostics segment. It outlines the client's problem of seeking new revenue sources and growth options. The document analyzes segments using the VESSEL framework, identifies point-of-care diagnostics as the most promising, and provides a SWOT analysis. Four companies are then shortlisted in this segment based on an assessment framework. The most attractive target, a pharmaceutical IT company, is identified based on organizational compatibility, synergy, and financial considerations.
Four Practical Approaches To Managing A More Effective Device Trial
This document discusses four practical approaches to managing effective device trials:
1) Consider the appropriate regulatory path and reimbursement strategy to maximize trial and product success.
2) Understand the patient population and customer setting to ensure the trial design reflects real-world use.
3) Incorporate complete trial visibility with technology-driven processes to efficiently manage operations.
4) Clinical trials require significant investment but technology can reduce costs while improving processes like enrollment and data management.
Technical Due Diligence
The document discusses conducting effective due diligence for business deals. It outlines three categories of due diligence: technical, commercial, and legal. Pre-deal due diligence involves initial checks like opportunity size and fit. Confirmatory due diligence aims to confirm information and find reasons not to proceed. An effective due diligence team represents key disciplines and has experience evaluating information within tight timeframes. Information requests cover areas like discovery, clinical trials, manufacturing, and compliance. Critical questions examine clinical trial design and whether data will support desired labeling. Potential problems include lack of access to data, staff, or incomplete information.
Sustaining Customer Relationships Rev 1
Whirlpool Corporation reported lower first quarter earnings compared to the previous year due to challenging economic conditions in the US market. While sales increased 5% to $4.6 billion, net earnings decreased 24% to $94 million due to a 9% decline in US appliance industry demand. Operating profit also declined due to higher material and oil costs and lower US volume. Whirlpool revised its full-year US industry demand forecast downward to a 5-6% decline. International operations showed improved results and offset some of the losses in North America.
Speeding Towards Commercialization Gra 121808 Final
The document discusses commercialization services for emerging biotechnology developments and medical devices. It introduces Secure BioMed Evaluations and Lassiter & Associates, who have expertise in bringing medical devices to market. Their services include evaluating commercial feasibility, regulatory pathway analysis, manufacturing analysis, reimbursement support, market validation, and market sizing to help clients expedite the process of getting products to market.
Maetrics: The ROI of Good Quality & Compliance
The document discusses investing in quality and compliance programs to justify costs. It outlines how to quantify direct and indirect quality costs, examines the FDA's increasing focus on medical devices, and explores the impacts of non-compliance. Proactive quality systems can reduce costs compared to reactive systems. Good investments include dedicated CAPA resources, risk management programs, quality metrics, and harmonizing quality systems during acquisitions.
New Product Planning Strategies to Ensure Organizational Robustness for Launch
- New product planning strategies are important for small to medium sized biopharma companies to ensure organizational robustness for product launches.
- Early commercial planning can impact a product's launch success by clearly defining its value proposition and positioning relative to competitors.
- A framework for evaluating new targets and indications involves assessing factors like clinical development feasibility, regulatory pathways, market potential, and risks. Strategic segmentation of patient populations also guides efficient planning.
- Lifecycle management strategies like pursuing new indications can extend revenue and provide competitive barriers to improve return on investment.
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Due Diligence - New Strategies for Successful Licensing Acquisitions , DIA , Session Panel, June 22 2008,
Clinical Recruitment Planning Strategies
The document discusses the importance of early clinical recruitment planning for drug development programs. It notes that delays in recruitment can significantly increase costs and impact revenue opportunities due to later market entry. Early planning allows consideration of factors like disease characteristics, enrollment population size, competition, and protocol challenges that influence feasibility. Comprehensive recruitment programs costing 1-12% of delay costs can help avoid delays and ensure timely trial completion and drug approval.
Converge Advisory Group
This document provides an introduction to Converge Advisory Group, an advisory firm that helps life sciences companies navigate challenges in research and development, regulatory approval processes, and commercialization. It outlines increasing costs of drug development and greater price pressures in the industry. Converge aims to provide strategic guidance through evidence-based solutions and leveraging artificial intelligence to analyze large datasets quickly. The firm works with pharmaceutical, biotech, and startup clients to develop strategies across a drug's lifecycle from discovery through commercialization.
1st Riyadh Marketing Club (Introduction to Business Development Management) ...
#Mahmoud_Bahgat
#Marketing_Club
Join us by WhatsApp to me 00966568654916
*اشترك في صفحة ال Marketing Club* عالفيسبوك
https://www.facebook.com/MarketingTipsPAGE/
*اشترك في جروب ال Marketing Club* عالفيسبوك
https://www.facebook.com/groups/837318003074869/
*Marketing Club Middle East*
25 Meetings in 6 Cities in 1 year & 2 months
Since October 2015
*We have 6 groups whatsapp*
*for almost 600 marketers*
From all middle east
*since 5 years*
& now 10 more groups
For Marketing Club Lovers as future Marketers
أهم حاجة الشروط
*Only marketers*
From all Industries
No students
*No sales*
*No hotels Reps*
*No restaurants Reps*
*No Travel Agents*
*No Advertising Agencies*
*Many have asked to Attend the Club*
((We Wish All can Attend,But Cant..))
*Criteria of Marketing Club Members*
•••••••••••••••••••••••••••••••••••••
For Better Harmony & Mind set.
*Must be only Marketer*
*Also Previous Marketing experience*
●Business Managers
●Country Manager,GM
●Directors, CEO
Are most welcomed to add Value to us.
■■■■■■■■■■■■■■■■
《 *Unmatched Criteria*》
Not Med Rep,
Not Key Account,
Not Product Specialist,
Not Sales Supervisor,
Not Sales Manager,
●●●●●●●●●●●●●●●●●●
But till you become a marketer
you can join other What'sApp group
*Marketing Lover Future Club Group*
■■■■■■■■■■■■■■■■
《 *Unmatched Criteria*》
For Conflict of Intrest
*Also Can't attend*
If Working in
*Marketing Services Provider*
=not *Hotel* Marketers
=not *Restaurant* Marketers
=not *Advertising* Marketer
=not *Event Manager*
=not *Market Researcher*.
■■■■■■■■■■■■■■■■
■■■■■■■■■■■■■■■■
*this Club for Only Marketers*
Very Soon we will have
*Business Leaders Club*
For Sales Managers & Directors
Will be Not for Markters
●●●●●●●●●●●●●●●●●●●●
■ *Only Marketers* ■
*& EPS Marketing Diploma*
●●●●●●●●●●●●●●●●●●●●
Confirm coming by Pvt WhatsApp
*To know the new Location*
*#Mahmoud_Bahgat*
00966568654916
*#Marketing_Club*
http://goo.gl/forms/RfskGzDslP
*اشترك بصفحة جمعية الصيادلة المصريين* عالفيسبوك
https://lnkd.in/fucnv_5
■ *Bahgat Facbook Page*
https://lnkd.in/fVAdubA
■ *Bahgat Linkedin*
https://lnkd.in/fvDQXuG
■ *Bahgat Twitter*
https://lnkd.in/fmNC72T
■ *Bahgat YouTube Channel*
https://www.Youtube.com /mahmoud bahgat
■ *Bahgat Instagram*
https://lnkd.in/fmWPXrY
■ *Bahgat SnapChat*
https://lnkd.in/f6GR-mR
*#Mahmoud_Bahgat*
*#Legendary_ADLAND*
www.TheLegendary.info
Webinar: Global Supply Chain Dynamics & The Changing Risk Management Agenda
This is the slide deck from the first of a two-part Webinar produced and moderated by Art Stewart in partnership with the Corporate Responsibility Association. It covers: Innovations in global supply chain management that are transforming the traditional sourcing paradigm; specific developments in key industries that are impacting supply chain dynamics; new opportunities for CR professionals to extend their C-suite influence via supply chain and risk matters; and a CR check list of strategies and tactics for mitigating emerging supply chain issues. Part II will be Wednesday, February 11, 2015 at 12 Noon EST.
OneStart 2015 London Bootcamp: Ilan Zipkin, Takeda Ventures - Development Pat...
OneStart 2015 London Bootcamp: Ilan Zipkin, Takeda Ventures - Development Pat...Oxbridge Biotech Roundtable
This document discusses different paths for development in the life sciences industry, including therapeutics, medical devices, diagnostics, research tools, and healthcare IT. It outlines the key hurdles, goals, and features that are important for investors at each stage of developing these types of companies. Specifically, it notes that the barrier to entry defines revenue expectations and potential, while the capital and time required to develop a product determines the necessary exit valuation. Overall regulatory requirements, clinical needs, sales potential, and other factors must all be addressed in a business plan to achieve the desired return on investment.ALP_AMD without recording file
The document provides a market analysis for an analytics company called AlphaMD to enter the pharmaceutical market in the UAE. It includes a literature review on the pharmaceutical sector in UAE, identifying key parameters and needs of target companies through interviews. Based on a decision matrix, marketing pharmaceutical companies were identified as the top target. Recommendations include providing competitive intelligence and contracting services at affordable prices while maintaining quality. Limitations include lack of financial data from SMEs and limited interviews.
9 regulatory compliance and validation for li
This document provides an overview of challenges facing the life sciences industry and discusses validation requirements for computer systems. It contains the following information:
- The pharmaceutical, medical device, and biotechnology industries face issues like loss of revenue from generics, high costs to develop new drugs, and new regulations. Computer validation is important in these regulated industries.
- FDA validation requirements are defined as demonstrating through documented evidence that a system consistently operates according to predetermined specifications. Validation ensures quality, objectivity, and that developers cannot check their own work.
- A validation toolkit is presented that follows GAMP 5 guidelines and parallels an established validation methodology. It contains templates, scripts, and tools to help customers efficiently validate computer systems in a
Strategic Sourcing Ppt Final
The document provides information about the Indian healthcare market, diagnostic industry in India, Biswayan Diagnostic Center (BDC), and suggestions for improving BDC's operations. It notes that the diagnostic equipment market in India is large and growing, and BDC aims to provide quality diagnostic services. It analyzes BDC's suppliers, procurement processes, use of IT, and challenges. Suggestions for BDC include investing more in IT, improving processes through documentation and standardization, and revising supplier selection criteria.
Touray moriba ba522week4-final rsearchprojct-global marketing _ppt
The document provides an overview of various marketing research and analysis tools including PESTEL analysis, SWOT analysis, segmentation, target markets, value propositions, competitive advantages, Hofstede's cultural dimensions, and the marketing mix (4Ps). It discusses how these concepts are used to evaluate business opportunities and develop effective marketing strategies when expanding into global markets. Key factors that must be considered for international market entry such as target markets, entry mode, timing, and exit strategies are also summarized.
Aagami Inc. Research Services Presentation
This document provides an overview of business and market research services offered by Aagami, Inc., a life sciences consulting firm. It describes the types of strategic consulting, market intelligence, competitive analysis, financial modeling, and other services they provide to biotech, pharmaceutical, medical device and consumer health companies. Examples of case studies are also provided where Aagami assisted clients with opportunities identification, market entry strategy, valuation analysis, and competitive landscape assessments.
Similar to How much does it cost to launch and commercialize a companion diagnostic test? (20)
CASE STUDY ON CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
CASE STUDY ON CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
Four Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device Trial
Speeding Towards Commercialization Gra 121808 Final
Speeding Towards Commercialization Gra 121808 Final
New Product Planning Strategies to Ensure Organizational Robustness for Launch
New Product Planning Strategies to Ensure Organizational Robustness for Launch
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
1st Riyadh Marketing Club (Introduction to Business Development Management) ...
1st Riyadh Marketing Club (Introduction to Business Development Management) ...
Webinar: Global Supply Chain Dynamics & The Changing Risk Management Agenda
Webinar: Global Supply Chain Dynamics & The Changing Risk Management Agenda
OneStart 2015 London Bootcamp: Ilan Zipkin, Takeda Ventures - Development Pat...
OneStart 2015 London Bootcamp: Ilan Zipkin, Takeda Ventures - Development Pat...
Touray moriba ba522week4-final rsearchprojct-global marketing _ppt
Touray moriba ba522week4-final rsearchprojct-global marketing _ppt
Recently uploaded
BONKMILLON Unleashes Its Bonkers Potential on Solana.pdf
Introducing BONKMILLON - The Most Bonkers Meme Coin Yet
Let's be real for a second – the world of meme coins can feel like a bit of a circus at times. Every other day, there's a new token promising to take you "to the moon" or offering some groundbreaking utility that'll change the game forever. But how many of them actually deliver on that hype?
Does teamwork really matter? Looking beyond the job posting to understand lab...
Does teamwork really matter? Looking beyond the job posting to understand lab...Labour Market Information Council | Conseil de l’information sur le marché du travail
Vicinity Jobs’ data includes more than three million 2023 OJPs and thousands of skills. Most skills appear in less than 0.02% of job postings, so most postings rely on a small subset of commonly used terms, like teamwork.
Laura Adkins-Hackett, Economist, LMIC, and Sukriti Trehan, Data Scientist, LMIC, presented their research exploring trends in the skills listed in OJPs to develop a deeper understanding of in-demand skills. This research project uses pointwise mutual information and other methods to extract more information about common skills from the relationships between skills, occupations and regions.Independent Study - College of Wooster Research (2023-2024) FDI, Culture, Glo...
Independent Study - College of Wooster Research (2023-2024) FDI, Culture, Glo...AntoniaOwensDetwiler
"Does Foreign Direct Investment Negatively Affect Preservation of Culture in the Global South? Case Studies in Thailand and Cambodia."
Do elements of globalization, such as Foreign Direct Investment (FDI), negatively affect the ability of countries in the Global South to preserve their culture? This research aims to answer this question by employing a cross-sectional comparative case study analysis utilizing methods of difference. Thailand and Cambodia are compared as they are in the same region and have a similar culture. The metric of difference between Thailand and Cambodia is their ability to preserve their culture. This ability is operationalized by their respective attitudes towards FDI; Thailand imposes stringent regulations and limitations on FDI while Cambodia does not hesitate to accept most FDI and imposes fewer limitations. The evidence from this study suggests that FDI from globally influential countries with high gross domestic products (GDPs) (e.g. China, U.S.) challenges the ability of countries with lower GDPs (e.g. Cambodia) to protect their culture. Furthermore, the ability, or lack thereof, of the receiving countries to protect their culture is amplified by the existence and implementation of restrictive FDI policies imposed by their governments.
My study abroad in Bali, Indonesia, inspired this research topic as I noticed how globalization is changing the culture of its people. I learned their language and way of life which helped me understand the beauty and importance of cultural preservation. I believe we could all benefit from learning new perspectives as they could help us ideate solutions to contemporary issues and empathize with others.falcon-invoice-discounting-a-premier-investment-platform-for-superior-returns...
falcon-invoice-discounting-a-premier-investment-platform-for-superior-returns...Falcon Invoice Discounting
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.Tdasx: In-Depth Analysis of Cryptocurrency Giveaway Scams and Security Strate...
Tdasx: In-Depth Analysis of Cryptocurrency Giveaway Scams and Security Strategies
一比一原版(UCL毕业证)伦敦大学|学院毕业证如何办理
UCL硕士学位证成绩单【微信95270640】《如何办理伦敦大学|学院毕业证认证》【办证Q微信95270640】《伦敦大学|学院文凭毕业证制作》《UCL学历学位证书哪里买》办理伦敦大学|学院学位证书扫描件、办理伦敦大学|学院雅思证书！
国际留学归国服务中心《如何办伦敦大学|学院毕业证认证》《UCL学位证书扫描件哪里买》实体公司，注册经营，行业标杆，精益求精！
专业为留学生办理伦敦大学|学院伦敦大学|学院毕业证offer【100%存档可查】留学全套申请材料办理。本公司承诺所有毕业证成绩单成品全部按照学校原版工艺对照一比一制作和学校一样的羊皮纸张保证您证书的质量！
如果你回国在学历认证方面有以下难题请联系我们我们将竭诚为你解决认证瓶颈
1所有材料真实但资料不全无法提供完全齐整的原件。【如：成绩单丶毕业证丶回国证明等材料中有遗失的。】
2获得真实的国外最终学历学位但国外本科学历就读经历存在问题或缺陷。【如：国外本科是教育部不承认的或者是联合办学项目教育部没有备案的或者外本科没有正常毕业的。】
3学分转移联合办学等情况复杂不知道怎么整理材料的。时间紧迫自己不清楚递交流程的。
如果你是以上情况之一请联系我们我们将在第一时间内给你免费咨询相关信息。我们将帮助你整理认证所需的各种材料.帮你解决国外学历认证难题。
国外伦敦大学|学院伦敦大学|学院毕业证offer办理方法：
1客户提供办理信息：姓名生日专业学位毕业时间等（如信息不确定可以咨询顾问：我们有专业老师帮你查询伦敦大学|学院伦敦大学|学院毕业证offer）；
2开始安排制作伦敦大学|学院毕业证成绩单电子图；
3伦敦大学|学院毕业证成绩单电子版做好以后发送给您确认；
4伦敦大学|学院毕业证成绩单电子版您确认信息无误之后安排制作成品；
5伦敦大学|学院成品做好拍照或者视频给您确认；
6快递给客户（国内顺丰国外DHLUPS等快读邮寄）。吃吃地笑山娃很精神越逛越起劲父亲却越逛越疲倦望着父亲呵欠连天的样子山娃也说困了累了回家吧小屋闷罐一般头顶上的三叶扇彻夜呜呜作响搅得满屋热气腾腾也搅得山娃心烦意乱父亲一上床就呼呼大睡山娃却辗转反侧睡不着山娃一次又一次摸索着爬起来一遍又一遍地用暖乎乎的冷水擦身往水泥地板上一勺一勺的洒水也不知过了多久山娃竟迷迷糊糊地睡着了迷迷糊糊地又闻到了闹钟刺耳的铃声和哐咣的关门声待山娃醒来时父亲早已上班去了床头总们
Pensions and housing - Pensions PlayPen - 4 June 2024 v3 (1).pdf
Wayhome's analysis of the UK market and how pension schemes can help solve the problems it presents younger people
Eco-Innovations and Firm Heterogeneity. Evidence from Italian Family and Nonf...
Eco-Innovations and Firm Heterogeneity. Evidence from Italian Family and Nonf...University of Calabria
The study analyzes differences and primary drivers of green performance between family firms and non-family firms
Earn a passive income with prosocial investing
Invest in prosocial funds that earn you an income while improving the world
^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Duba...
Whatsapp (+971581248768) Buy Abortion Pills In Dubai/ Qatar/Kuwait/Doha/Abu Dhabi/Alain/RAK City/Satwa/Al Ain/Abortion Pills For Sale In Qatar, Doha. Abu az Zuluf. Abu Thaylah. Ad Dawhah al Jadidah. Al Arish, Al Bida ash Sharqiyah, Al Ghanim, Al Ghuwariyah, Qatari, Abu Dhabi, Dubai.. WHATSAPP +971)581248768 Abortion Pills / Cytotec Tablets Available in Dubai, Sharjah, Abudhabi, Ajman, Alain, Fujeira, Ras Al Khaima, Umm Al Quwain., UAE, buy cytotec in Dubai– Where I can buy abortion pills in Dubai,+971582071918where I can buy abortion pills in Abudhabi +971)581248768 , where I can buy abortion pills in Sharjah,+97158207191 8where I can buy abortion pills in Ajman, +971)581248768 where I can buy abortion pills in Umm al Quwain +971)581248768 , where I can buy abortion pills in Fujairah +971)581248768 , where I can buy abortion pills in Ras al Khaimah +971)581248768 , where I can buy abortion pills in Alain+971)581248768 , where I can buy abortion pills in UAE +971)581248768 we are providing cytotec 200mg abortion pill in dubai, uae.Medication abortion offers an alternative to Surgical Abortion for women in the early weeks of pregnancy. Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman
falcon-invoice-discounting-a-strategic-approach-to-optimize-investments
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
一比一原版(UoB毕业证)伯明翰大学毕业证如何办理
UoB本科学位证成绩单【微信95270640】伯明翰大学没毕业>办理伯明翰大学毕业证成绩单【微信UoB】UoB毕业证成绩单UoB学历证书UoB文凭《UoB毕业套号文凭网认证伯明翰大学毕业证成绩单》《哪里买伯明翰大学毕业证文凭UoB成绩学校快递邮寄信封》《开版伯明翰大学文凭》UoB留信认证本科硕士学历认证
如果您是以下情况，我们都能竭诚为您解决实际问题：【公司采用定金+余款的付款流程，以最大化保障您的利益，让您放心无忧】
1、在校期间，因各种原因未能顺利毕业，拿不到官方毕业证+微信95270640
2、面对父母的压力，希望尽快拿到伯明翰大学伯明翰大学硕士毕业证成绩单；
3、不清楚流程以及材料该如何准备伯明翰大学伯明翰大学硕士毕业证成绩单；
4、回国时间很长，忘记办理；
5、回国马上就要找工作，办给用人单位看；
6、企事业单位必须要求办理的；
面向美国乔治城大学毕业留学生提供以下服务:
【★伯明翰大学伯明翰大学硕士毕业证成绩单毕业证、成绩单等全套材料，从防伪到印刷，从水印到钢印烫金，与学校100%相同】
【★真实使馆认证（留学人员回国证明），使馆存档可通过大使馆查询确认】
【★真实教育部认证，教育部存档，教育部留服网站可查】
【★真实留信认证，留信网入库存档，可查伯明翰大学伯明翰大学硕士毕业证成绩单】
我们从事工作十余年的有着丰富经验的业务顾问，熟悉海外各国大学的学制及教育体系，并且以挂科生解决毕业材料不全问题为基础，为客户量身定制1对1方案，未能毕业的回国留学生成功搭建回国顺利发展所需的桥梁。我们一直努力以高品质的教育为起点，以诚信、专业、高效、创新作为一切的行动宗旨，始终把“诚信为主、质量为本、客户第一”作为我们全部工作的出发点和归宿点。同时为海内外留学生提供大学毕业证购买、补办成绩单及各类分数修改等服务；归国认证方面，提供《留信网入库》申请、《国外学历学位认证》申请以及真实学籍办理等服务，帮助众多莘莘学子实现了一个又一个梦想。
专业服务，请勿犹豫联系我
如果您真实毕业回国，对于学历认证无从下手，请联系我，我们免费帮您递交
诚招代理：本公司诚聘当地代理人员，如果你有业余时间，或者你有同学朋友需要，有兴趣就请联系我
你赢我赢，共创双赢
你做代理，可以帮助伯明翰大学同学朋友
你做代理，可以拯救伯明翰大学失足青年
你做代理，可以挽救伯明翰大学一个个人才
你做代理，你将是别人人生伯明翰大学的转折点
你做代理，可以改变自己，改变他人，给他人和自己一个机会大块就啃啃得满嘴满脸猴屁股般的红艳大家一个劲地指着对方吃吃地笑瓜裂得古怪奇形怪状却丝毫不影响瓜味甜丝丝的满嘴生津遍地都是瓜横七竖八的活像掷满了一地的大石块摘走二三只爷爷是断然发现不了的即便发现爷爷也不恼反而教山娃辨认孰熟孰嫩孰甜孰淡名义上是护瓜往往在瓜棚里坐上一刻饱吃一顿后山娃就领着阿黑漫山遍野地跑阿黑是一条黑色的大猎狗挺机灵的是山娃多年的忠实伙伴平时山娃上学阿黑也摇头晃脑地跟去暑假用不着上学阿钩
Tdasx: Unveiling the Trillion-Dollar Potential of Bitcoin DeFi
Tdasx: Unveiling the Trillion-Dollar Potential of Bitcoin DeFi
一比一原版(UCSB毕业证)圣芭芭拉分校毕业证如何办理
UCSB毕业证文凭证书【微信95270640】办理圣芭芭拉分校毕业证成绩单（Q微信95270640）毕业证学历认证OFFER专卖国外文凭学历学位证书办理澳洲文凭|澳洲毕业证,澳洲学历认证,澳洲成绩单 澳洲offer,教育部学历认证及使馆认证永久可查 ,国外毕业证|国外学历认证,国外学历文凭证书 UCSB毕业证，UCSB毕业证，UCSB毕业证，UCSB毕业证，UCSB毕业证，UCSB毕业证，UCSB毕业证，专业为留学生办理毕业证、成绩单、使馆留学回国人员证明、教育部学历学位认证、录取通知书、Offer、
【实体公司】办圣芭芭拉分校圣芭芭拉分校毕业证成绩单学历认证学位证文凭认证办留信网认证办留服认证办教育部认证（网上可查实体公司专业可靠）
— — — 留学归国服务中心 — — -
【主营项目】
一.圣芭芭拉分校毕业证成绩单使馆认证教育部认证成绩单等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
国外毕业证学位证成绩单办理流程：
1客户提供圣芭芭拉分校圣芭芭拉分校毕业证成绩单办理信息：姓名生日专业学位毕业时间等（如信息不确定可以咨询顾问：我们有专业老师帮你查询）；
2开始安排制作毕业证成绩单电子图；
3毕业证成绩单电子版做好以后发送给您确认；
4毕业证成绩单电子版您确认信息无误之后安排制作成品；
5成品做好拍照或者视频给您确认；
6快递给客户（国内顺丰国外DHLUPS等快读邮寄）。
专业服务请勿犹豫联系我！本公司是留学创业和海归创业者们的桥梁。一次办理终生受用一步到位高效服务。详情请在线咨询办理,欢迎有诚意办理的客户咨询!洽谈。
招聘代理：本公司诚聘英国加拿大澳洲新西兰美国法国德国新加坡各地代理人员如果你有业余时间有兴趣就请联系我们咨询顾问：+微信:95270640田里逡巡一番抱起一只硕大的西瓜用石刀劈开抑或用拳头砸开每人抱起一大块就啃啃得满嘴满脸猴屁股般的红艳大家一个劲地指着对方吃吃地笑瓜裂得古怪奇形怪状却丝毫不影响瓜味甜丝丝的满嘴生津遍地都是瓜横七竖八的活像掷满了一地的大石块摘走二三只爷爷是断然发现不了的即便发现爷爷也不恼反而教山娃辨认孰熟孰嫩孰甜孰淡名义上是护瓜往往在瓜棚里坐上一刻饱吃一顿后山娃就领着阿黑漫山遍野地跑阿黑是一条黑色的大猎狗挺机灵的是山室
The Impact of GST Payments on Loan Approvals
Understanding how timely GST payments influence a lender's decision to approve loans, this topic explores the correlation between GST compliance and creditworthiness. It highlights how consistent GST payments can enhance a business's financial credibility, potentially leading to higher chances of loan approval.
1：1制作加拿大麦吉尔大学毕业证硕士学历证书原版一模一样
原版一模一样【微信：741003700 】【加拿大麦吉尔大学毕业证硕士学历证书】【微信：741003700 】学位证，留信认证（真实可查，永久存档）offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原海外各大学 Bachelor Diploma degree, Master Degree Diploma
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
Independent Study - College of Wooster Research (2023-2024)
"Does Foreign Direct Investment Negatively Affect Preservation of Culture in the Global South? Case Studies in Thailand and Cambodia."
Do elements of globalization, such as Foreign Direct Investment (FDI), negatively affect the ability of countries in the Global South to preserve their culture? This research aims to answer this question by employing a cross-sectional comparative case study analysis utilizing methods of difference. Thailand and Cambodia are compared as they are in the same region and have a similar culture. The metric of difference between Thailand and Cambodia is their ability to preserve their culture. This ability is operationalized by their respective attitudes towards FDI; Thailand imposes stringent regulations and limitations on FDI while Cambodia does not hesitate to accept most FDI and imposes fewer limitations. The evidence from this study suggests that FDI from globally influential countries with high gross domestic products (GDPs) (e.g. China, U.S.) challenges the ability of countries with lower GDPs (e.g. Cambodia) to protect their culture. Furthermore, the ability, or lack thereof, of the receiving countries to protect their culture is amplified by the existence and implementation of restrictive FDI policies imposed by their governments.
My study abroad in Bali, Indonesia, inspired this research topic as I noticed how globalization is changing the culture of its people. I learned their language and way of life which helped me understand the beauty and importance of cultural preservation. I believe we could all benefit from learning new perspectives as they could help us ideate solutions to contemporary issues and empathize with others.
Recently uploaded (20)
BONKMILLON Unleashes Its Bonkers Potential on Solana.pdf
BONKMILLON Unleashes Its Bonkers Potential on Solana.pdf
Does teamwork really matter? Looking beyond the job posting to understand lab...
Does teamwork really matter? Looking beyond the job posting to understand lab...
Independent Study - College of Wooster Research (2023-2024) FDI, Culture, Glo...
Independent Study - College of Wooster Research (2023-2024) FDI, Culture, Glo...
falcon-invoice-discounting-a-premier-investment-platform-for-superior-returns...
falcon-invoice-discounting-a-premier-investment-platform-for-superior-returns...
Tdasx: In-Depth Analysis of Cryptocurrency Giveaway Scams and Security Strate...
Tdasx: In-Depth Analysis of Cryptocurrency Giveaway Scams and Security Strate...
Pensions and housing - Pensions PlayPen - 4 June 2024 v3 (1).pdf
Pensions and housing - Pensions PlayPen - 4 June 2024 v3 (1).pdf
Eco-Innovations and Firm Heterogeneity. Evidence from Italian Family and Nonf...
Eco-Innovations and Firm Heterogeneity. Evidence from Italian Family and Nonf...
^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Duba...
^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Duba...
falcon-invoice-discounting-a-strategic-approach-to-optimize-investments
falcon-invoice-discounting-a-strategic-approach-to-optimize-investments
Tdasx: Unveiling the Trillion-Dollar Potential of Bitcoin DeFi
Tdasx: Unveiling the Trillion-Dollar Potential of Bitcoin DeFi
Independent Study - College of Wooster Research (2023-2024)
Independent Study - College of Wooster Research (2023-2024)
How much does it cost to launch and commercialize a companion diagnostic test?
- 1. We asked four senior executives in the pharma and diagnostic industry to come up with a value on how much it would cost to launch and commercialize a novel diagnostic test. Here’s what they came up with. HOW MUCH DOES IT COST TO LAUNCH AND COMMERCIALIZE A COMPANION DIAGNOSTIC TEST? LOW END Development and Manufacturing Costs (US $million) Technology acquisition and protection QSR and FDA compliance GMP manufacturing Platform development ( buy in or make) R&D ( based on 1-3 years of FTEs at 200k/yr loaded spend) Clinical Utility trials retrospective versus prospective Admin and financing 0.6 1 3 0.5 3 3 8 1 3 5 10 20 5 4 20.1Total costs to commercialize 3 1 4 2 2 10 25 12 12.1 55Subtotal costs to launch 8 51Subtotal costs to drive adoption Sales and Marketing Costs ( US market only) Direct sales team ( assuming required for 3 years) Health technology assessment and payer negotiations Clinical education ( guidelines - KOL endorsement multi stakeholder education) Marketing ( launch meetings, representative detail aids, online marketing) Definitions Low end - a follow on diagnostic product where a similar test exists in the market a High end - a new biomarker (needing to establish novel clinical utility), or a new platform likely to be in oncology, a chronic disease like RA or a range of infectious markers requiring panel performance. Source - http://www.diaceutics.com/mystery-solved-what-cost-develop-and-launch-diagnostic#sthash.lqtwab8H.dpuf LOW END HIGH END HIGH END 106